LAUSR

Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process.

Sign Up to like & get
recommendations!
0 Published in 2017 at "Anticancer research"

DOI: 10.21873/anticanres.11729

Abstract: BACKGROUND/AIM Changes in epidermal growth factor receptor (EGFR) are commonly found in cancer progression, signaling a poor outcome in patients. In the present study, we aimed to investigate whether nimotuzumab could be of benefit for… read more here.

Keywords: suppression; metastasis via; cell metastasis; metastasis ... See more keywords